EquityBulls

Latest News

Keywords Selected: Licensing

Stock Report

Zydus' new drug discovery, 'Desidustat' licensed to China Medical System Holdings receives approval from NMPA of China
Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries
Biocon Ltd signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries
Venus Remedies Marks Completion of AMR Licensing Milestones with Final Rs. 11 Crore Payment
Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market
Shilpa Medicare announces Strategic Partnership with Orion Corporation for Recombinant Human Albumin for European Market
Suprajit Announces Licensing and Technology Transfer Agreement with Blubrake for Next Generation Anti-lock Braking System
Biocon Ltd partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 products in the Middle East region
Zydus announces exclusive licensing and supply agreement for two Gadolinium based MRI injectable, contrast agents in the US
Biocon Ltd signs an exclusive licensing and supply agreement for generic Ozempic commercialization in Brazil with Biomm S.A.
Zydus and Synthon enter into an exclusive licensing and supply agreement for Palbociclib Tablets for the US market
Aurobindo announces signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis for 90 countries including India